Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12078634 Broad spectrum kinase binding agents

Patent 12078634 was granted and assigned to Promega on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Matthew Robers0

Cesear Corona0

James Vasta0

Poncho Meisenheimer0

Date of Patent

September 3, 2024

0

Patent Application Number

178197840

Date Filed

August 15, 2022

0

Patent Citations

US Patent 7867726 Compositions comprising a dehalogenase substrate and a fluorescent label and methods of use

0

US Patent 7884098 Anthranilamide inhibitors of aurora kinase

0

US Patent 8557970 Synthetic

0

US Patent 8669103 Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use

0

US Patent 9056885 Carboxy X rhodamine analogs

0

US Patent 8901120 Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the Axl kinase

0

US Patent 7238842 Covalent tethering of functional groups to proteins

0

US Patent 7425436 Covalent tethering of functional groups to proteins and substrates therefor

0

...

Patent Primary Examiner

D Margaret M Seaman

0

CPC Code

0

0

0

0

0

0

0

0

Patent abstract

Provided herein are compounds that are broad-spectrum protein kinase binding agents, detectable tracers comprising such compounds, and method of use thereof for the detection of protein kinases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12078634 Broad spectrum kinase binding agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool